ArticleBMJ open2021

Prospective, multicentre, randomised controlled trial comparing the seroclearance of HBsAg between combination therapy of peg-interferon alpha and tenofovir with tenofovir monotherapy in nucleos(t)ide analogue-experienced patients with HBV-related liver fibrosis: a study protocol.

Shu Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.